As Chief Technology Officer, Bryce contributes to the machine learning and technology platforms supporting Inherent Biosciences' diagnostic products. Bryce obtained a B.S. in Bioinformatics from Brigham Young University and a Ph.D. in Human Genetics from Baylor College of Medicine. Subsequently, he served as VP of Product at clinical genomic software companies Tute Genomics and PierianDx. Currently, Bryce is also Co-founder and Chief Technology Officer at Modulus Therapeutics, a Seattle-based cell therapy company, which was incubated at the Allen Institute for Artificial Intelligence while he was an Entrepreneur-in-Residence.